Natalie Sturgeon
Physician Assistant · Trenton, TNNPI 1457514614
Payments from drug & device makers
Across 498 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$1K
- Novo Nordisk$741
- Pfizer$608
- Lilly USA, LLC$488
- AstraZeneca$389
- plus $4K from 28 others
What the payments were for
- Travel & lodging$7729%
- Food & beverage$8,01991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $1,565 |
| AbbVie | 94 | $1,186 |
| Novo Nordisk | 42 | $741 |
| Pfizer | 43 | $608 |
| Lilly USA, LLC | 42 | $488 |
| AstraZeneca | 26 | $389 |
| Merck | 24 | $380 |
| Otsuka America Pharmaceutical, Inc. | 23 | $356 |
| Bayer | 19 | $305 |
| Amgen | 23 | $298 |
| Lundbeck LLC | 16 | $289 |
| Biohaven Pharmaceuticals, Inc. | 15 | $268 |
| Mylan Specialty L.p. | 14 | $265 |
| Johnson & Johnson | 16 | $231 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $198 |
| GSK | 10 | $187 |
| Sumitomo Pharma America, Inc. | 8 | $143 |
| Esperion Therapeutics, Inc. | 6 | $124 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $84 |
| Supernus Pharmaceuticals, Inc. | 5 | $73 |
| Exact Sciences | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $53 |
| Dexcom, Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Eisai Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| Sunovion Pharmaceuticals Inc. | 3 | $43 |
| Abbott | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Astellas Pharma US Inc | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Novartis | 1 | $19 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,791 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 120 | $138,679 |
| JardianceEmpagliflozin | 106 | $107,163 |
| TrulicityDulaglutide | 101 | $100,378 |
| FarxigaDapagliflozin Propanediol | 77 | $58,378 |
| EliquisApixaban | 72 | $50,185 |
| VraylarCariprazine Hcl | 23 | $41,622 |
| Abilify MaintenaAripiprazole | 15 | $40,499 |
| LinzessLinaclotide | 51 | $40,289 |
| KerendiaFinerenone | 28 | $28,341 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $27,378 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $25,050 |
| MyrbetriqMirabegron | 33 | $20,209 |
| JanuviaSitagliptin Phosphate | 11 | $17,414 |
| RexultiBrexpiprazole | 12 | $17,392 |
| QuliptaAtogepant | 15 | $15,878 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $741 | $138,679120 claims |
| Boehringer IngelheimJardiance | $13 | $107,163106 claims |
| Lilly USA, LLCTrulicity | $488 | $100,378101 claims |
| AbbVieVraylar, Linzess, Qulipta | $1,186 | $97,78989 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $389 | $95,869120 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $356 | $57,89127 claims |
| PfizerEliquis | $608 | $50,18572 claims |
| MerckJanuvia, Belsomra, Janumet Xr | $380 | $35,57046 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $187 | $32,67041 claims |
| BayerKerendia | $305 | $28,34128 claims |
| Astellas Pharma US IncMyrbetriq | $32 | $20,20933 claims |
| Johnson & JohnsonXarelto | $231 | $12,26314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Trenton
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.